1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Precision Cancer Therapies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Hormone Therapy 1.2.3 Immunotherapies 1.2.4 Targeted Therapy 1.2.5 Monoclonal Antibody Therapy 1.2.6 Gene Therapy 1.3 Market by Application 1.3.1 Global Precision Cancer Therapies Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Diagnostic Centers 1.3.4 Oncology Clinics 1.3.5 Research Institutes 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Precision Cancer Therapies Market Perspective (2016-2027) 2.2 Precision Cancer Therapies Growth Trends by Regions 2.2.1 Precision Cancer Therapies Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Precision Cancer Therapies Historic Market Share by Regions (2016-2021) 2.2.3 Precision Cancer Therapies Forecasted Market Size by Regions (2022-2027) 2.3 Precision Cancer Therapies Industry Dynamic 2.3.1 Precision Cancer Therapies Market Trends 2.3.2 Precision Cancer Therapies Market Drivers 2.3.3 Precision Cancer Therapies Market Challenges 2.3.4 Precision Cancer Therapies Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Precision Cancer Therapies Players by Revenue 3.1.1 Global Top Precision Cancer Therapies Players by Revenue (2016-2021) 3.1.2 Global Precision Cancer Therapies Revenue Market Share by Players (2016-2021) 3.2 Global Precision Cancer Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Precision Cancer Therapies Revenue 3.4 Global Precision Cancer Therapies Market Concentration Ratio 3.4.1 Global Precision Cancer Therapies Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Precision Cancer Therapies Revenue in 2020 3.5 Precision Cancer Therapies Key Players Head office and Area Served 3.6 Key Players Precision Cancer Therapies Product Solution and Service 3.7 Date of Enter into Precision Cancer Therapies Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Precision Cancer Therapies Breakdown Data by Type 4.1 Global Precision Cancer Therapies Historic Market Size by Type (2016-2021) 4.2 Global Precision Cancer Therapies Forecasted Market Size by Type (2022-2027) 5 Precision Cancer Therapies Breakdown Data by Application 5.1 Global Precision Cancer Therapies Historic Market Size by Application (2016-2021) 5.2 Global Precision Cancer Therapies Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Precision Cancer Therapies Market Size (2016-2027) 6.2 North America Precision Cancer Therapies Market Size by Type 6.2.1 North America Precision Cancer Therapies Market Size by Type (2016-2021) 6.2.2 North America Precision Cancer Therapies Market Size by Type (2022-2027) 6.2.3 North America Precision Cancer Therapies Market Size by Type (2016-2027) 6.3 North America Precision Cancer Therapies Market Size by Application 6.3.1 North America Precision Cancer Therapies Market Size by Application (2016-2021) 6.3.2 North America Precision Cancer Therapies Market Size by Application (2022-2027) 6.3.3 North America Precision Cancer Therapies Market Size by Application (2016-2027) 6.4 North America Precision Cancer Therapies Market Size by Country 6.4.1 North America Precision Cancer Therapies Market Size by Country (2016-2021) 6.4.2 North America Precision Cancer Therapies Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Precision Cancer Therapies Market Size (2016-2027) 7.2 Europe Precision Cancer Therapies Market Size by Type 7.2.1 Europe Precision Cancer Therapies Market Size by Type (2016-2021) 7.2.2 Europe Precision Cancer Therapies Market Size by Type (2022-2027) 7.2.3 Europe Precision Cancer Therapies Market Size by Type (2016-2027) 7.3 Europe Precision Cancer Therapies Market Size by Application 7.3.1 Europe Precision Cancer Therapies Market Size by Application (2016-2021) 7.3.2 Europe Precision Cancer Therapies Market Size by Application (2022-2027) 7.3.3 Europe Precision Cancer Therapies Market Size by Application (2016-2027) 7.4 Europe Precision Cancer Therapies Market Size by Country 7.4.1 Europe Precision Cancer Therapies Market Size by Country (2016-2021) 7.4.2 Europe Precision Cancer Therapies Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Precision Cancer Therapies Market Size (2016-2027) 8.2 Asia-Pacific Precision Cancer Therapies Market Size by Type 8.2.1 Asia-Pacific Precision Cancer Therapies Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Precision Cancer Therapies Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Precision Cancer Therapies Market Size by Type (2016-2027) 8.3 Asia-Pacific Precision Cancer Therapies Market Size by Application 8.3.1 Asia-Pacific Precision Cancer Therapies Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Precision Cancer Therapies Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Precision Cancer Therapies Market Size by Application (2016-2027) 8.4 Asia-Pacific Precision Cancer Therapies Market Size by Region 8.4.1 Asia-Pacific Precision Cancer Therapies Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Precision Cancer Therapies Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Precision Cancer Therapies Market Size (2016-2027) 9.2 Latin America Precision Cancer Therapies Market Size by Type 9.2.1 Latin America Precision Cancer Therapies Market Size by Type (2016-2021) 9.2.2 Latin America Precision Cancer Therapies Market Size by Type (2022-2027) 9.2.3 Latin America Precision Cancer Therapies Market Size by Type (2016-2027) 9.3 Latin America Precision Cancer Therapies Market Size by Application 9.3.1 Latin America Precision Cancer Therapies Market Size by Application (2016-2021) 9.3.2 Latin America Precision Cancer Therapies Market Size by Application (2022-2027) 9.3.3 Latin America Precision Cancer Therapies Market Size by Application (2016-2027) 9.4 Latin America Precision Cancer Therapies Market Size by Country 9.4.1 Latin America Precision Cancer Therapies Market Size by Country (2016-2021) 9.4.2 Latin America Precision Cancer Therapies Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Precision Cancer Therapies Market Size (2016-2027) 10.2 Middle East & Africa Precision Cancer Therapies Market Size by Type 10.2.1 Middle East & Africa Precision Cancer Therapies Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Precision Cancer Therapies Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Precision Cancer Therapies Market Size by Type (2016-2027) 10.3 Middle East & Africa Precision Cancer Therapies Market Size by Application 10.3.1 Middle East & Africa Precision Cancer Therapies Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Precision Cancer Therapies Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Precision Cancer Therapies Market Size by Application (2016-2027) 10.4 Middle East & Africa Precision Cancer Therapies Market Size by Country 10.4.1 Middle East & Africa Precision Cancer Therapies Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Precision Cancer Therapies Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Abbott Laboratories 11.1.1 Abbott Laboratories Company Details 11.1.2 Abbott Laboratories Business Overview 11.1.3 Abbott Laboratories Precision Cancer Therapies Introduction 11.1.4 Abbott Laboratories Revenue in Precision Cancer Therapies Business (2016-2021) 11.1.5 Abbott Laboratories Recent Development 11.2 Bayer HealthCare 11.2.1 Bayer HealthCare Company Details 11.2.2 Bayer HealthCare Business Overview 11.2.3 Bayer HealthCare Precision Cancer Therapies Introduction 11.2.4 Bayer HealthCare Revenue in Precision Cancer Therapies Business (2016-2021) 11.2.5 Bayer HealthCare Recent Development 11.3 GlaxoSmithKline 11.3.1 GlaxoSmithKline Company Details 11.3.2 GlaxoSmithKline Business Overview 11.3.3 GlaxoSmithKline Precision Cancer Therapies Introduction 11.3.4 GlaxoSmithKline Revenue in Precision Cancer Therapies Business (2016-2021) 11.3.5 GlaxoSmithKline Recent Development 11.4 OncoGenex Pharmaceuticals 11.4.1 OncoGenex Pharmaceuticals Company Details 11.4.2 OncoGenex Pharmaceuticals Business Overview 11.4.3 OncoGenex Pharmaceuticals Precision Cancer Therapies Introduction 11.4.4 OncoGenex Pharmaceuticals Revenue in Precision Cancer Therapies Business (2016-2021) 11.4.5 OncoGenex Pharmaceuticals Recent Development 11.5 Hospira 11.5.1 Hospira Company Details 11.5.2 Hospira Business Overview 11.5.3 Hospira Precision Cancer Therapies Introduction 11.5.4 Hospira Revenue in Precision Cancer Therapies Business (2016-2021) 11.5.5 Hospira Recent Development 11.6 Boehringer Ingelheim 11.6.1 Boehringer Ingelheim Company Details 11.6.2 Boehringer Ingelheim Business Overview 11.6.3 Boehringer Ingelheim Precision Cancer Therapies Introduction 11.6.4 Boehringer Ingelheim Revenue in Precision Cancer Therapies Business (2016-2021) 11.6.5 Boehringer Ingelheim Recent Development 11.7 AstraZeneca 11.7.1 AstraZeneca Company Details 11.7.2 AstraZeneca Business Overview 11.7.3 AstraZeneca Precision Cancer Therapies Introduction 11.7.4 AstraZeneca Revenue in Precision Cancer Therapies Business (2016-2021) 11.7.5 AstraZeneca Recent Development 11.8 Aveo Pharmaceuticals 11.8.1 Aveo Pharmaceuticals Company Details 11.8.2 Aveo Pharmaceuticals Business Overview 11.8.3 Aveo Pharmaceuticals Precision Cancer Therapies Introduction 11.8.4 Aveo Pharmaceuticals Revenue in Precision Cancer Therapies Business (2016-2021) 11.8.5 Aveo Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Precision Cancer Therapies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Hormone Therapy Table 3. Key Players of Immunotherapies Table 4. Key Players of Targeted Therapy Table 5. Key Players of Monoclonal Antibody Therapy Table 6. Key Players of Gene Therapy Table 7. Global Precision Cancer Therapies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Precision Cancer Therapies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Precision Cancer Therapies Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global Precision Cancer Therapies Market Share by Regions (2016-2021) Table 11. Global Precision Cancer Therapies Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global Precision Cancer Therapies Market Share by Regions (2022-2027) Table 13. Precision Cancer Therapies Market Trends Table 14. Precision Cancer Therapies Market Drivers Table 15. Precision Cancer Therapies Market Challenges Table 16. Precision Cancer Therapies Market Restraints Table 17. Global Precision Cancer Therapies Revenue by Players (2016-2021) & (US$ Million) Table 18. Global Precision Cancer Therapies Market Share by Players (2016-2021) Table 19. Global Top Precision Cancer Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Precision Cancer Therapies as of 2020) Table 20. Ranking of Global Top Precision Cancer Therapies Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by Precision Cancer Therapies Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Precision Cancer Therapies Product Solution and Service Table 24. Date of Enter into Precision Cancer Therapies Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Precision Cancer Therapies Market Size by Type (2016-2021) (US$ Million) Table 27. Global Precision Cancer Therapies Revenue Market Share by Type (2016-2021) Table 28. Global Precision Cancer Therapies Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Precision Cancer Therapies Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global Precision Cancer Therapies Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global Precision Cancer Therapies Revenue Market Share by Application (2016-2021) Table 32. Global Precision Cancer Therapies Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Precision Cancer Therapies Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America Precision Cancer Therapies Market Size by Type (2016-2021) (US$ Million) Table 35. North America Precision Cancer Therapies Market Size by Type (2022-2027) & (US$ Million) Table 36. North America Precision Cancer Therapies Market Size by Application (2016-2021) (US$ Million) Table 37. North America Precision Cancer Therapies Market Size by Application (2022-2027) & (US$ Million) Table 38. North America Precision Cancer Therapies Market Size by Country (2016-2021) & (US$ Million) Table 39. North America Precision Cancer Therapies Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe Precision Cancer Therapies Market Size by Type (2016-2021) (US$ Million) Table 41. Europe Precision Cancer Therapies Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe Precision Cancer Therapies Market Size by Application (2016-2021) (US$ Million) Table 43. Europe Precision Cancer Therapies Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe Precision Cancer Therapies Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe Precision Cancer Therapies Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific Precision Cancer Therapies Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific Precision Cancer Therapies Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific Precision Cancer Therapies Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific Precision Cancer Therapies Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific Precision Cancer Therapies Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific Precision Cancer Therapies Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America Precision Cancer Therapies Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America Precision Cancer Therapies Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America Precision Cancer Therapies Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America Precision Cancer Therapies Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America Precision Cancer Therapies Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America Precision Cancer Therapies Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa Precision Cancer Therapies Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa Precision Cancer Therapies Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa Precision Cancer Therapies Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa Precision Cancer Therapies Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa Precision Cancer Therapies Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa Precision Cancer Therapies Market Size by Country (2022-2027) & (US$ Million) Table 64. Abbott Laboratories Company Details Table 65. Abbott Laboratories Business Overview Table 66. Abbott Laboratories Precision Cancer Therapies Product Table 67. Abbott Laboratories Revenue in Precision Cancer Therapies Business (2016-2021) & (US$ Million) Table 68. Abbott Laboratories Recent Development Table 69. Bayer HealthCare Company Details Table 70. Bayer HealthCare Business Overview Table 71. Bayer HealthCare Precision Cancer Therapies Product Table 72. Bayer HealthCare Revenue in Precision Cancer Therapies Business (2016-2021) & (US$ Million) Table 73. Bayer HealthCare Recent Development Table 74. GlaxoSmithKline Company Details Table 75. GlaxoSmithKline Business Overview Table 76. GlaxoSmithKline Precision Cancer Therapies Product Table 77. GlaxoSmithKline Revenue in Precision Cancer Therapies Business (2016-2021) & (US$ Million) Table 78. GlaxoSmithKline Recent Development Table 79. OncoGenex Pharmaceuticals Company Details Table 80. OncoGenex Pharmaceuticals Business Overview Table 81. OncoGenex Pharmaceuticals Precision Cancer Therapies Product Table 82. OncoGenex Pharmaceuticals Revenue in Precision Cancer Therapies Business (2016-2021) & (US$ Million) Table 83. OncoGenex Pharmaceuticals Recent Development Table 84. Hospira Company Details Table 85. Hospira Business Overview Table 86. Hospira Precision Cancer Therapies Product Table 87. Hospira Revenue in Precision Cancer Therapies Business (2016-2021) & (US$ Million) Table 88. Hospira Recent Development Table 89. Boehringer Ingelheim Company Details Table 90. Boehringer Ingelheim Business Overview Table 91. Boehringer Ingelheim Precision Cancer Therapies Product Table 92. Boehringer Ingelheim Revenue in Precision Cancer Therapies Business (2016-2021) & (US$ Million) Table 93. Boehringer Ingelheim Recent Development Table 94. AstraZeneca Company Details Table 95. AstraZeneca Business Overview Table 96. AstraZeneca Precision Cancer Therapies Product Table 97. AstraZeneca Revenue in Precision Cancer Therapies Business (2016-2021) & (US$ Million) Table 98. AstraZeneca Recent Development Table 99. Aveo Pharmaceuticals Company Details Table 100. Aveo Pharmaceuticals Business Overview Table 101. Aveo Pharmaceuticals Revenue in Precision Cancer Therapies Business (2016-2021) & (US$ Million) Table 102. Aveo Pharmaceuticals Recent Development Table 103. Research Programs/Design for This Report Table 104. Key Data Information from Secondary Sources Table 105. Key Data Information from Primary Sources List of Figures Figure 1. Global Precision Cancer Therapies Market Share by Type: 2020 VS 2027 Figure 2. Hormone Therapy Features Figure 3. Immunotherapies Features Figure 4. Targeted Therapy Features Figure 5. Monoclonal Antibody Therapy Features Figure 6. Gene Therapy Features Figure 7. Global Precision Cancer Therapies Market Share by Application: 2020 VS 2027 Figure 8. Hospitals Case Studies Figure 9. Diagnostic Centers Case Studies Figure 10. Oncology Clinics Case Studies Figure 11. Research Institutes Case Studies Figure 12. Precision Cancer Therapies Report Years Considered Figure 13. Global Precision Cancer Therapies Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 14. Global Precision Cancer Therapies Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Precision Cancer Therapies Market Share by Regions: 2020 VS 2027 Figure 16. Global Precision Cancer Therapies Market Share by Regions (2022-2027) Figure 17. Global Precision Cancer Therapies Market Share by Players in 2020 Figure 18. Global Top Precision Cancer Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Precision Cancer Therapies as of 2020 Figure 19. The Top 10 and 5 Players Market Share by Precision Cancer Therapies Revenue in 2020 Figure 20. Global Precision Cancer Therapies Revenue Market Share by Type (2016-2021) Figure 21. Global Precision Cancer Therapies Revenue Market Share by Type (2022-2027) Figure 22. North America Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. North America Precision Cancer Therapies Market Share by Type (2016-2027) Figure 24. North America Precision Cancer Therapies Market Share by Application (2016-2027) Figure 25. North America Precision Cancer Therapies Market Share by Country (2016-2027) Figure 26. United States Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Canada Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Precision Cancer Therapies Market Share by Type (2016-2027) Figure 30. Europe Precision Cancer Therapies Market Share by Application (2016-2027) Figure 31. Europe Precision Cancer Therapies Market Share by Country (2016-2027) Figure 32. Germany Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. France Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. U.K. Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Italy Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Russia Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Nordic Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Precision Cancer Therapies Market Share by Type (2016-2027) Figure 40. Asia-Pacific Precision Cancer Therapies Market Share by Application (2016-2027) Figure 41. Asia-Pacific Precision Cancer Therapies Market Share by Region (2016-2027) Figure 42. China Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Japan Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. South Korea Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Southeast Asia Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. India Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Australia Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Precision Cancer Therapies Market Share by Type (2016-2027) Figure 50. Latin America Precision Cancer Therapies Market Share by Application (2016-2027) Figure 51. Latin America Precision Cancer Therapies Market Share by Country (2016-2027) Figure 52. Mexico Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Brazil Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Precision Cancer Therapies Market Share by Type (2016-2027) Figure 56. Middle East & Africa Precision Cancer Therapies Market Share by Application (2016-2027) Figure 57. Middle East & Africa Precision Cancer Therapies Market Share by Country (2016-2027) Figure 58. Turkey Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Saudi Arabia Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. UAE Precision Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. Abbott Laboratories Revenue Growth Rate in Precision Cancer Therapies Business (2016-2021) Figure 62. Bayer HealthCare Revenue Growth Rate in Precision Cancer Therapies Business (2016-2021) Figure 63. GlaxoSmithKline Revenue Growth Rate in Precision Cancer Therapies Business (2016-2021) Figure 64. OncoGenex Pharmaceuticals Revenue Growth Rate in Precision Cancer Therapies Business (2016-2021) Figure 65. Hospira Revenue Growth Rate in Precision Cancer Therapies Business (2016-2021) Figure 66. Boehringer Ingelheim Revenue Growth Rate in Precision Cancer Therapies Business (2016-2021) Figure 67. AstraZeneca Revenue Growth Rate in Precision Cancer Therapies Business (2016-2021) Figure 68. Aveo Pharmaceuticals Revenue Growth Rate in Precision Cancer Therapies Business (2016-2021) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed

Abbott Laboratories Bayer HealthCare GlaxoSmithKline OncoGenex Pharmaceuticals Hospira Boehringer Ingelheim AstraZeneca Aveo Pharmaceuticals